HL 46296/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1993	2
1994	2
1995	1
1996	4
1997	2
1998	3
1999	1
2000	1
2001	3
2002	5
2003	1
2004	3
2005	3
2006	6
2007	5
2008	2
2009	2
2010	2
2011	1
2024	0

1

Prostaglandin catabolic enzymes as tumor suppressors.

Tai HH. Tai HH. Cancer Metastasis Rev. 2011 Dec;30(3-4):409-17. doi: 10.1007/s10555-011-9314-z. Cancer Metastasis Rev. 2011. PMID: 22020925 Review.

2

Thromboxanes: synthase and receptors.

Shen RF, Tai HH. Shen RF, et al. J Biomed Sci. 1998;5(3):153-72. doi: 10.1007/BF02253465. J Biomed Sci. 1998. PMID: 9678486 Review.

3

NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions.

Tai HH, Cho H, Tong M, Ding Y. Tai HH, et al. Curr Pharm Des. 2006;12(8):955-62. doi: 10.2174/138161206776055958. Curr Pharm Des. 2006. PMID: 16533162 Review.

4

15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.

Tai HH, Tong M, Ding Y. Tai HH, et al. Prostaglandins Other Lipid Mediat. 2007 May;83(3):203-8. doi: 10.1016/j.prostaglandins.2007.01.007. Epub 2007 Jan 17. Prostaglandins Other Lipid Mediat. 2007. PMID: 17481556 Free PMC article. Review.

5

15-Hydroxyprostaglandin dehydrogenase suppresses K-RasV12-dependent tumor formation in Nu/Nu mice.

Pham H, Eibl G, Vincenti R, Chong B, Tai HH, Slice LW. Pham H, et al. Mol Carcinog. 2008 Jun;47(6):466-77. doi: 10.1002/mc.20404. Mol Carcinog. 2008. PMID: 18058808

6

Key NAD+-binding residues in human 15-hydroxyprostaglandin dehydrogenase.

Cho H, Hamza A, Zhan CG, Tai HH. Cho H, et al. Arch Biochem Biophys. 2005 Jan 15;433(2):447-53. doi: 10.1016/j.abb.2004.09.036. Arch Biochem Biophys. 2005. PMID: 15581601

7

Phosphorylation and desensitization of the human thromboxane receptor-alpha by G protein-coupled receptor kinases.

Zhou H, Yan F, Tai HH. Zhou H, et al. J Pharmacol Exp Ther. 2001 Sep;298(3):1243-51. J Pharmacol Exp Ther. 2001. PMID: 11504827

8

Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2.

Cho H, Huang L, Hamza A, Gao D, Zhan CG, Tai HH. Cho H, et al. Bioorg Med Chem. 2006 Oct 1;14(19):6486-91. doi: 10.1016/j.bmc.2006.06.030. Epub 2006 Jul 7. Bioorg Med Chem. 2006. PMID: 16828555

9

Histone deacetylase inhibitors and transforming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells.

Tong M, Ding Y, Tai HH. Tong M, et al. Biochem Pharmacol. 2006 Sep 14;72(6):701-9. doi: 10.1016/j.bcp.2006.06.004. Epub 2006 Jul 17. Biochem Pharmacol. 2006. PMID: 16844092

10

Activation of extracellular signal-regulated kinase by 12-hydroxyheptadecatrienoic acid in prostate cancer PC3 cells.

Li X, Wei J, Tai HH. Li X, et al. Arch Biochem Biophys. 2007 Nov 1;467(1):20-30. doi: 10.1016/j.abb.2007.08.005. Epub 2007 Aug 22. Arch Biochem Biophys. 2007. PMID: 17880908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

45 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year